Cash Rich Pfizer Splashing $7 Billion On Arena Acquisition Makes Sense - Here's WhySeeking Alpha • 12/17/21
Pfizer says its ultra-low dose vaccine isn't enough for kids aged 2-5 — setting up a booster scenario that could delay toddlers' shots until mid-2022Business Insider • 12/17/21
Pfizer Plans To Evaluate Third Shot For Its COVID-19 Vaccine In Kids Below 5 YearsBenzinga • 12/17/21
Pfizer Submits Application For Approval Of COVID-19 Shot For Adolescents Aged 12 To 15Benzinga • 12/17/21
Here's Why Shares of Bristol Myers Squibb, Eli Lilly, and Pfizer Rocketed Higher This WeekThe Motley Fool • 12/17/21
Moderna, Pfizer Covid Vaccines Should Be Given Over Johnson & Johnson's, CDC Advisory Board SaysForbes • 12/16/21
CDC expert panel prefers Pfizer, Moderna vaccines over J&J shots for adults due to rare blood clot casesCNBC • 12/16/21
EMA Issues Advice for Potential Early Use of Pfizer's Novel COVID-19 Oral Antiviral CandidateBusiness Wire • 12/16/21